|
|
Atividade
| 34048 - Strategies in cancer drug discovery and development. |
| Período da turma: | 14/09/2009 a 17/09/2009
|
||||
|
|
|||||
| Descrição: | PROGRAMA:
Aberrant signal transduction pathways in cancer. Target validation in oncology. Use of genetic model organism in cancer research and drug discovery. Targeted anti-cancer therapy and emergence of resistance. Target of topoisomerase II and ATPase in cancer. Target the Hsp90 ATPase in cancer. A novel target of chronic myeloproliferative disorders. Rapamycins: An exciting journey from the Eastern island to bedside. REFERÊNCIA BIBLIOGRÁFICA: STEPHEN NEIDLE. Cancer - Drug design and Discovery. CHARLES STREULI. The molecular basis of breast cancer prevention and treatment. |
||||
| Carga Horária: |
9 horas |
||||
| Tipo: | Obrigatória | ||||
| Vagas oferecidas: | 50 | ||||
| Ministrantes: |
Roberto Santana da Silva Sofia Nikolaou Thomas Alexander Radimerski |
 voltar |
|
Créditos © 1999 - 2025 - Superintendência de Tecnologia da Informação/USP |